Aurobindo Pharma Q1 profit slips 12% to Rs 455 crore


The Economic Times reports:
New Delhi: Drug firm Aurobindo Pharma today reported a 12.10 per cent decline in its consolidated net profit to Rs 455.59 crore for the first quarter ended June 30, mainly on account of rise in expenses. The company had posted a net profit of Rs 518.33 crore in the corresponding period previous fiscal, Aurobindo Pharma said in a BSE filing. The company's revenue from operations stood at Rs 4,250.27 crore for the quarter under consideration. It was Rs 3,678.75 crore for the year-ago period.
Continue reading...   Reader  
More trending news   Where is the full article?

LUV

SAD

WOW

MEH

GRR

HUH

LOL

0

0

0

0

0

0

0

This story is trending. Share it.